β2-glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss
- 31 March 2000
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 73 (3) , 531-535
- https://doi.org/10.1016/s0015-0282(99)00573-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Anti–β2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndromeAmerican Journal of Obstetrics and Gynecology, 1999
- Antibodies to β2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence studyFertility and Sterility, 1998
- Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndromeRheumatology, 1996
- Clinical significance of β2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: Correlation with conventional antiphospholipid antibody detection systemsAmerican Journal of Obstetrics and Gynecology, 1995
- Antiphospholipid antibodies in pregnancy: prevalence and clinical associationsBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- What is the "true" antigen for anticardiolipin antibodies?The Lancet, 1991
- Pregnancy-associated immunological disordersCurrent Opinion in Immunology, 1989
- β2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregationAtherosclerosis, 1987
- Anticardiolipin antibodies—clinical associationsPostgraduate Medical Journal, 1986
- Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-IBiochimica et Biophysica Acta (BBA) - General Subjects, 1986